Filter Results:
(681)
Show Results For
- All HBS Web
(1,175)
- People (3)
- News (201)
- Research (681)
- Events (5)
- Multimedia (7)
- Faculty Publications (324)
Show Results For
- All HBS Web
(1,175)
- People (3)
- News (201)
- Research (681)
- Events (5)
- Multimedia (7)
- Faculty Publications (324)
Sort by
- April 2010 (Revised January 2013)
- Case
California's Budget Crises, Tax Reform, and Domestic and International Tax Competition
By: Matthew C. Weinzierl and Jacob Kuipers
How do (and how should) governments design fiscal policies to compete in a globalized economy while meeting internal policy priorities including redistribution? In 2009, Governor Arnold Schwarzenegger repeatedly declared fiscal emergencies as California's state budget... View Details
Keywords: Budgets and Budgeting; Economy; Globalization; Governing Rules, Regulations, and Reforms; Policy; Taxation; Competition; California
Weinzierl, Matthew C., and Jacob Kuipers. "California's Budget Crises, Tax Reform, and Domestic and International Tax Competition." Harvard Business School Case 710-038, April 2010. (Revised January 2013.)
- January 2004 (Revised September 2004)
- Background Note
Confidentiality in Settlement Negotiations: Ethics & Law
By: Michael A. Wheeler, Dana Nelson and Gillian Morris
Legal policy has a long history of protecting confidentiality of negotiations that are designed to produce settlement. However, within the past several decades there has been a significant push toward openness. Compelling arguments support confidentiality: It helps... View Details
Keywords: Ethics; Lawsuits and Litigation; Attorney and Client Relationships; Policy; Corporate Disclosure; Negotiation
Wheeler, Michael A., Dana Nelson, and Gillian Morris. "Confidentiality in Settlement Negotiations: Ethics & Law." Harvard Business School Background Note 904-057, January 2004. (Revised September 2004.)
- December 2022
- Article
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies." Journal of Health Politics, Policy and Law 47, no. 6 (December 2022): 629–648.
- 29 Oct 2020
- Research & Ideas
The COVID Gender Gap: Why Fewer Women Are Dying
According to a survey of citizens in eight countries, women are much more likely than men to view COVID-19 as a severe health problem. They are also more willing to wear face masks and follow other public View Details
- 14 Mar 2017
- First Look
First Look at New Research, March 14
abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52217 2016 Monetary Policy Through Asset Markets: Lessons from Unconventional Measures and Implications for an Integrated World Forward Guidance in the... View Details
Keywords: Sean Silverthorne
- Research Summary
Overview
By: Kyle R. Myers
Professor Myers studies the economics of what determines the rate and direction of innovation. He has examined the reallocation of scientists through the use of targeted research grants at the National Institutes of Health, and is working to further understand how... View Details
Keywords: Technology Networks; Commercialization; Science-Based Business; Research and Development; Knowledge Management; Patents; Innovation Strategy; Technological Innovation; Health Care and Treatment; Entrepreneurship; Health; Innovation and Invention; Science; Technology; Knowledge; Intellectual Property; Economics; Microeconomics; Health Industry; Health Industry; Health Industry; Health Industry
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- 11 Sep 2008
- Working Paper Summaries
Competing Complements
- 02 Jan 2018
- First Look
First Look at New Research and Ideas, January 3, 2018
government turns out to be different from that in the United States. It shows that big business emerged as a constructive player in environmental policy in the 1960s, when it persuaded the government to establish a joint research... View Details
Keywords: Sean Silverthorne
- 12 Aug 2014
- First Look
First Look: August 12
http://hbr.org/product/aspada-in-search-of-the-right-structure-for-impact-investing/an/314099-PDF-ENG Harvard Business School Case 214-085 Financial Policy at Apple, 2013 (A) By the end of 2013, Apple had $137 billion in cash and... View Details
Keywords: Sean Silverthorne
- April 2007 (Revised March 2008)
- Case
Dr. Iqbal Survé at Sekunjalo Investment Group (A)
By: Linda A. Hill and Emily Stecker
Dr. Iqbal Surve, a self-described "medical doctor, philanthropist, and social entrepreneur," was born in 1963 and grew up in poverty, like virtually all non-white South Africans during apartheid. During the 1970s and 1980s, he served in leadership positions in the ANC,... View Details
Keywords: Crime and Corruption; Social Entrepreneurship; Investment; Leadership; Corporate Social Responsibility and Impact; Partners and Partnerships; South Africa
Hill, Linda A., and Emily Stecker. "Dr. Iqbal Survé at Sekunjalo Investment Group (A)." Harvard Business School Case 407-019, April 2007. (Revised March 2008.)
- 17 Sep 2019
- Cold Call Podcast
How a New Leader Broke Through a Culture of Accuse, Blame, and Criticize
- 24 Aug 2016
- Research & Ideas
Can Obamacare Be Saved?
On August 15th, Aetna announced that it would reduce by 80 percent its participation in the Obama administration’s public exchanges for health insurance policies in 2017, citing significant financial losses.... View Details
- 2015
- Working Paper
Expertise vs. Bias in Evaluation: Evidence from the NIH
By: Danielle Li
Evaluators with expertise in a particular field may have an informational advantage in separating good projects from bad. At the same time, they may also have personal preferences that impact their objectivity. This paper develops a framework for separately identifying... View Details
Li, Danielle. "Expertise vs. Bias in Evaluation: Evidence from the NIH." Harvard Business School Working Paper, No. 16-053, October 2015.
- September 2012 (Revised August 2015)
- Case
Shanghai Pharmaceuticals
By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Health Industry; Health Industry; Shanghai; United States; Europe
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
- 09 Jan 2014
- Working Paper Summaries
Economic Transition and Private-Sector Labor Demand: Evidence from Urban China
- 28 Oct 2011
- Working Paper Summaries
Fairness, Efficiency, and Flexibility in Organ Allocation for Kidney Transplantation
- October 2018 (Revised January 2019)
- Case
The Financial Crisis: Timothy Geithner and the Stress Tests
In February and March 2009, the U.S. economy was in the midst of a terrifying financial and economic crisis. Between the beginning of 2008 and early 2009, four of the 25 largest U.S. financial institutions had failed, and nine of these 25 institutions had taken... View Details
Keywords: Bailout; Regulation; Stress Test; Financial Crisis; History; Economy; Policy; Governing Rules, Regulations, and Reforms; Decision Making; Banking Industry; Financial Services Industry; Real Estate Industry; United States
Hanson, Samuel G., Robin Greenwood, David Scharfstein, and Adi Sunderam. "The Financial Crisis: Timothy Geithner and the Stress Tests." Harvard Business School Case 219-038, October 2018. (Revised January 2019.)
- 2011
- Working Paper
Fairness, Efficiency and Flexibility in Organ Allocation for Kidney Transplantation
By: Dimitris Bertsimas, Vivek F. Farias and Nikolaos Trichakis
We propose a scalable, data-driven method for designing national policies for the allocation of deceased donor kidneys to patients on a waiting list, in a fair and efficient way. We focus on policies that have the same form as the one currently used in the U.S. In... View Details
Keywords: Fairness; Policy; Health Disorders; Marketplace Matching; Performance Effectiveness; Rank and Position; Health Industry; United States
Bertsimas, Dimitris, Vivek F. Farias, and Nikolaos Trichakis. "Fairness, Efficiency and Flexibility in Organ Allocation for Kidney Transplantation." Harvard Business School Working Paper, No. 12-025, October 2011.
- Research Summary
Fairness and Efficiency in Resource Allocation
In studying the relationship of fairness and efficiency, Professor Trichakis takes the novel approach of looking at varied industries for unifying factors, and he pays special attention to inequities by incorporating both quantitative work in social welfare and the... View Details